[go: up one dir, main page]

TR199900506T2 - Yeni y�ntemler. - Google Patents

Yeni y�ntemler.

Info

Publication number
TR199900506T2
TR199900506T2 TR1999/00506T TR9900506T TR199900506T2 TR 199900506 T2 TR199900506 T2 TR 199900506T2 TR 1999/00506 T TR1999/00506 T TR 1999/00506T TR 9900506 T TR9900506 T TR 9900506T TR 199900506 T2 TR199900506 T2 TR 199900506T2
Authority
TR
Turkey
Prior art keywords
new methods
idoxy
women
post
treatment
Prior art date
Application number
TR1999/00506T
Other languages
English (en)
Turkish (tr)
Inventor
N. Bradbeer Jeremy
Gowen Maxime
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR199900506T2 publication Critical patent/TR199900506T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR1999/00506T 1996-09-06 1997-09-03 Yeni y�ntemler. TR199900506T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24

Publications (1)

Publication Number Publication Date
TR199900506T2 true TR199900506T2 (xx) 1999-07-21

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1999/00506T TR199900506T2 (xx) 1996-09-06 1997-09-03 Yeni y�ntemler.
TR1999/00504T TR199900504T2 (xx) 1996-09-06 1997-09-03 Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR1999/00504T TR199900504T2 (xx) 1996-09-06 1997-09-03 Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi

Country Status (16)

Country Link
EP (2) EP0927029A4 (fr)
JP (2) JP2002515047A (fr)
KR (2) KR20000068472A (fr)
CN (2) CN1236299A (fr)
AR (1) AR008155A1 (fr)
AU (2) AU4247397A (fr)
BR (2) BR9711676A (fr)
CA (2) CA2264943A1 (fr)
CO (2) CO5070658A1 (fr)
CZ (1) CZ76699A3 (fr)
IL (1) IL128645A0 (fr)
NO (2) NO991096D0 (fr)
PL (2) PL332278A1 (fr)
TR (2) TR199900506T2 (fr)
TW (1) TW411273B (fr)
WO (2) WO1998009619A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034608A1 (fr) * 1997-02-11 1998-08-13 Novo Nordisk A/S Methodes therapeutiques ou prophylactiques a l'encontre de symptomes menopausiques
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (fr) * 1986-09-11 1990-05-09 National Research Development Corporation Dérivés du tamoxifène
KR100326962B1 (ko) * 1992-09-15 2002-12-02 메렐 파마슈티칼스 인크. 타목시펜-내성종양치료용비대사성클로미펜유사체
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
CA2223595C (fr) * 1995-06-07 2008-08-05 Neorx Corporation Prevention et traitement de pathologies cardio-vasculaires au moyen d'analogues de tamoxifene
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
NO991096L (no) 1999-03-05
EP0929216A1 (fr) 1999-07-21
PL332038A1 (en) 1999-08-16
EP0927029A4 (fr) 2001-06-13
IL128645A0 (en) 2000-01-31
KR20000068473A (ko) 2000-11-25
BR9711676A (pt) 1999-08-24
CA2264943A1 (fr) 1998-03-12
AR008155A1 (es) 1999-12-09
NO991096D0 (no) 1999-03-05
AU4247397A (en) 1998-03-26
JP2002515047A (ja) 2002-05-21
JP2002515046A (ja) 2002-05-21
NO991097L (no) 1999-03-05
CN1236299A (zh) 1999-11-24
CZ76699A3 (cs) 1999-08-11
CO4920218A1 (es) 2000-05-29
CO5070658A1 (es) 2001-08-28
PL332278A1 (en) 1999-08-30
EP0927029A1 (fr) 1999-07-07
WO1998009519A1 (fr) 1998-03-12
CN1236313A (zh) 1999-11-24
TR199900504T2 (xx) 1999-06-21
TW411273B (en) 2000-11-11
WO1998009619A1 (fr) 1998-03-12
EP0929216A4 (fr) 2001-04-04
CA2264775A1 (fr) 1998-03-12
NO991097D0 (no) 1999-03-05
KR20000068472A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
DE69530701D1 (de) Verwendung von 2,7,8-Trimethyl-2-( beta-Carboxyethyl )-6-Hydroxy-Chroman (LLU-alpha)
EP1012795A4 (fr) Procedes de mesure de la flaccidite de billets de banque
BG39293A3 (bg) Метод за получаване на карбоксиалкилни дипептиди
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
NO975747L (no) Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
BG38334A3 (en) Method for preparing pyrolidinic derivatives
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
TR199900506T2 (xx) Yeni y�ntemler.
DZ2292A1 (fr) Méthode concernant l'immortalité des cellules.
ATE243036T1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
PL318213A1 (en) Method of obtaining 3-(methylothio) propanal
DE69736180D1 (de) Behandlung von manischen erkrankungen
UA19335A (uk) Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу
BG37839A3 (bg) Метод за получаване на производни на ортокондензиран пирол
JPS53107151A (en) Method of dephosphorizing waste water
IT1133899B (it) Rivestimento refrattario per siviere e procedimento per la sua fabbricazione
BG29285A3 (bg) Метод за получаване на 3-ди-n пропилацетокси бензодиазепин-2-они
DE69526156D1 (de) Verwendung des 1,3-Undecadien-5-yne als Duftstoff
IL116168A0 (en) Kit for cycle of treatment of osteoporosis
DE3369732D1 (en) Method of determination of human urine kallikrein and kit for the same
SE9300735L (sv) Startblock
ZA967962B (en) Method for determining the ovulation period of fertile women.